Kim Kerstann, PhD, has been named chief administrative officer of Winship Cancer Institute of Emory University.
Winship Cancer Institute of Emory University has named Kimberly Kerstann, PhD, as its new chief administrative officer.
Kerstann, who joined Winship in 2008, currently serves as senior director for cancer research administration and is a member of Winship's senior leadership team. During her tenure, Winship expanded its clinical and research infrastructure, successfully renewed its Cancer Center Support Grant two times, and achieved national recognition as a National Cancer Institute (NCI)-designated comprehensive cancer center.
In this expanded role, Kerstann will oversee Winship's administrative, business, and clinical research operations. She will provide leadership and oversight of grants administration, research operations, program and shared resource development, finance, strategic planning, space and facilities, information technology, personnel, and community partnerships and outreach.
"We are extremely fortunate to have such an experienced, talented leader as Dr. Kerstann expertly guiding so many critical aspects of Winship," said Suresh Ramalingam, MD, Winship's executive director and the Roberto C. Goizueta Distinguished Chair for Cancer Research. "For more than a decade, she has been instrumental to advancing Winship’s mission, increasing resources, strengthening infrastructure, and driving innovation. She is ideally suited to excel in her new role."
"I'm honored to be named chief administrative officer and to have the opportunity to build on our important work supporting the outstanding clinical and research community at Winship," said Kerstann. "Our teams are transforming how cancers are targeted, treated, and survived, and Winship is committed to expanding and deepening that impact as we plan for the future."
Kerstann earned her PhD in Genetics and Molecular Biology from Emory University and completed postdoctoral fellowships in genetic epidemiology at the National Human Genome Research Institute and the National Cancer Institute. She received the Emory Award of Distinction in 2017 in recognition of her outstanding contributions to the Emory community.
Nationally, Kerstann serves on the External Advisory Board member for three NCI-designated cancer centers and two aspiring NCI-designated centers. She is a member of the American Society of Clinical Oncology (ASCO), Association of Cancer Executive (ACE), Association of American Cancer Institutes (AACI), and the Cancer Center Administrators Forum (CCAF) completing a three-year term on the CCAF executive committee in 2021. She also completed a term on the AACI Clinical Research Initiative Steering Committee.
